Vertex Pharmaceuticals Incorporated
Jasper van Grunsven (EVP, CP and NPPO) reports VRTX insider transactions
About this filing
Vertex Pharmaceuticals Incorporated (VRTX) filed Form 4 (insider transaction) with the SEC on Sep 10, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Jasper van Grunsven · EVP, CP and NPPO
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | A · grantFootnotes F1 | +8,682 | $0.00 | $0.00 | 8,682 | Direct |
Footnotes
- F1 Restricted stock unit award that vests in installments beginning on 09/08/2027.
More VRTX filings
- 4
Filed Oct 22, 2026
- 3
Filed Oct 22, 2026
- 8-K
Filed Oct 20, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.